Meet
Megan Caruso

she/her
Associate Principal

Megan Caruso manages quality improvement projects for healthcare organizations, applying her background in mixed methods research, quality measurement, data collection, and value-based payment program design.

In recent projects, Megan has helped clients address persistent health issues in underserved patient populations, differentiate medical products in saturated markets, propose new quality measures to fill gaps in the existing market, and map the quality landscape most relevant to clients’ products.

Before joining Avalere, Megan Caruso served as an advisory services analyst at Mathematica, a policy research firm, where she worked across the Human Services and Health Divisions in data collection, policy research, and program improvement. She supported CMS across a range of quality reporting and payment programs, focused on Medicare beneficiaries in skilled nursing facilities and hospitals.  She developed expertise in quality reporting program implementation, program design, quality measure development and maintenance, public reporting, and stakeholder engagement and education.

Megan holds a BA magna cum laude in international relations with highest distinction and psychology with honors from California State University of Chico.

Authored Content

June 27, 2025 | Insights & Analysis > Federal and State Policy

Supreme Court Upholds Zero-Cost Preventive-Care Rule
In Kennedy v. Braidwood, the Supreme Court affirmed HHS’s USPSTF appointment power, keeping the ACA’s no-cost preventive-service mandate fully in force.
June 26, 2025 | Insights & Analysis > Vaccines and Public Health

President Trump’s Proposed AHRQ Cuts Would Impact Preventive Care Access
If finalized, the President’s FY 2026 proposed budget cuts and restructuring of AHRQ is anticipated to impede key USPSTF activities.
June 24, 2025 | Insights & Analysis > Value-Based Care

Quality is Critical to Manufacturers’ Commercialization Strategies
Quality is the bedrock of high-value care and should be a critical focus for manufacturers seeking to ensure access, coverage, and widespread adoption of therapies in clinical practice.
June 6, 2025 | Insights & Analysis > Drug Pricing and Affordability

White Paper: The Role of PBMs in the US Healthcare System
A new white paper describes the role of PBMs in the US healthcare system using evidence published in the literature to inform future discussions.
April 24, 2025 | Insights & Analysis > Coverage and Payment

USPSTF at a Crossroads: Preventive Care Coverage Mandate at SCOTUS
The Supreme Court weighs a case that could reshape access to no-cost preventive services under the ACA and redefine USPSTF's legal authority
March 7, 2025 | Insights & Analysis > RWE and Patient-Centered Outcomes

Stakeholders Can Influence Patient-Centered Value Research During Public Comment Period
Life sciences companies, payers, and advocates can weigh in on patient-centered value assessments in a new public comment opportunity.
February 14, 2024 | Insights & Analysis > RWE and Patient-Centered Outcomes

Limb Loss and Limb Difference: US Prevalence and Impact
Avalere and the Amputee Coalition analyzed claims data to understand the prevalence of limb loss and limb difference and the implications for public policy.